In:
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Vol. 21, No. 5 ( 1982-05), p. 848-851
Kurzfassung:
The in vitro activity of a new oral antimicrobial agent, norfloxacin (MK-0366), was compared with those of nalidixic acid, nitrofurantoin, co-trimoxazole, trimethoprim, sulfamethoxazole, cinoxacin, tetracycline, ampicillin, carbenicillin, and cephalexin against 628 urinary bacterial isolates. Norfloxacin was the most active antimicrobial agent tested against the gram-negative bacilli. It was less active than a few of the other antimicrobial agents against enterococci and Staphylococcus aureus.
Materialart:
Online-Ressource
ISSN:
0066-4804
,
1098-6596
DOI:
10.1128/AAC.21.5.848
Sprache:
Englisch
Verlag:
American Society for Microbiology
Publikationsdatum:
1982
ZDB Id:
1496156-8
SSG:
12
SSG:
15,3
Permalink